Splenomegaly News and Research

RSS
Enlargement of the spleen is called splenomegaly and can occur as a result of many infections, tumors, and hereditary or acquired conditions of the blood leading to hemolysis. The enlarged spleen may also become overactive, devouring too many blood cells and producing other symptoms.
Unraveling the role of TAL1 and miR-146b-5p in T-cell acute lymphoblastic leukemia

Unraveling the role of TAL1 and miR-146b-5p in T-cell acute lymphoblastic leukemia

Multi-center study validates systemic score in identifying high-risk patients with Still's disease

Multi-center study validates systemic score in identifying high-risk patients with Still's disease

Study reveals anti-inflammatory power of Black Soldier Fly Larvae oil in inflammatory-related conditions

Study reveals anti-inflammatory power of Black Soldier Fly Larvae oil in inflammatory-related conditions

Researchers uncover genetic machinery responsible for EBV-induced B cell growth transformation

Researchers uncover genetic machinery responsible for EBV-induced B cell growth transformation

Using AI might afford large-scale evaluation for splenomegaly on CT examinations

Using AI might afford large-scale evaluation for splenomegaly on CT examinations

Mast cells play a crucial role in the development of chronic myeloid leukemia

Mast cells play a crucial role in the development of chronic myeloid leukemia

Pioneering AI-based approach identifies rare disease patients using electronic health records

Pioneering AI-based approach identifies rare disease patients using electronic health records

Patients with myelofibrosis show improvement in disease-related symptoms when treated with momelotinib

Patients with myelofibrosis show improvement in disease-related symptoms when treated with momelotinib

Molecular virologist receives nearly $2 million NIH grant renewal to study hepatitis E virus

Molecular virologist receives nearly $2 million NIH grant renewal to study hepatitis E virus

Study reveals how a regulatory molecule ensures appropriate supply of blood cells

Study reveals how a regulatory molecule ensures appropriate supply of blood cells

Hedgehog blockade promising in myeloid malignancies

Hedgehog blockade promising in myeloid malignancies

Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

Pocket-sized ultrasound device reduce need for further testing in inpatient and outpatient settings

Pocket-sized ultrasound device reduce need for further testing in inpatient and outpatient settings

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

Researchers review effectiveness of RDTs in diagnosing visceral leishmaniasis

Researchers review effectiveness of RDTs in diagnosing visceral leishmaniasis

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

New method that targets mosquito larvae and pupae may help control malaria

New method that targets mosquito larvae and pupae may help control malaria

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.